Diltiazem Market Scope and Analysis by 2028
Diltiazem Market Report Scope
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 369.95 Million |
Market Size by 2028 | US$ 832.51 Million |
Global CAGR (2021 - 2028) | 12.3% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Product Type
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
Diltiazem Market – Segmentation
By Product Type
- Tablet
- Capsules
- Injection
By Application
- Hypertension
- Angina
- Others
Diltiazem Market– by Geography
- North America
- US
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of APAC
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA
- South and Central America (SCAM)
- Brazil
- Argentina
- Rest of SCAM
Company Profiles
- Bausch Health
- Teva Pharmaceutical Industries Ltd
- Mylan N.V
- Athenex
- Pfizer, Inc,
- Glenmark
- Sandoz (Novartis Ag)
- Sun Pharmaceutical Company Ltd
- Hikma Pharmaceuticals
- Zydus Pharmaceuticals